↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

67 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 [rituximab] Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 14 💬
2 Abatacept, rituximab or tocilizumab Abatacept 3件: D02596, D02994, D03203 💬 4件: CD80, CD86, IL6R, MS4A1 💬 24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor 1件: 46 💬
3 Abp 798 - biosimilar to rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
4 Abp 798 biosimilar to rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
5 Administration of rituximab and methylprednisolone Methylprednisolone 7件: D00407, D00751, D00979, D02994, D05000, D05001, D05002 💬 2件: MS4A1, NR3C1 💬 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 1件: 51 💬
6 Alemtuzumab and rituximab Alemtuzumab 2件: D02802, D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 60 💬
7 Alemtuzumab, rituximab Alemtuzumab 2件: D02802, D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 63 💬
8 Bendamustine, rituximab Bendamustine 3件: D02994, D07085, D07501 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 61 💬
9 Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine Azathioprine 12件: D00238, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994, D03033 💬 2件: MS4A1, NR3C1 💬 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 1件: 35 💬
10 Combined plasma exchange (pex), rituximab, and corticosteroids Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 85 💬
11 Dexamethasone and rituximab Dexamethasone 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994 💬 2件: MS4A1, NR3C1 💬 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 1件: 63 💬
12 Double-blind rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 51 💬
13 Dr. reddy’s rituximab (drl_ri) 100mg Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
14 Dr. reddy’s rituximab (drl_ri) 500mg Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
15 Eltrombopag combining rituximab Eltrombopag 2件: D02994, D03978 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 63 💬
16 Etanercepet, rituximab, abatacept, tocilizumab, sarilumab Abatacept 4件: D02596, D02994, D03203, D10161 💬 4件: CD80, CD86, IL6R, MS4A1 💬 24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor 1件: 46 💬
17 Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 222 💬
18 Gp2013 - a proposed biosimilar rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
19 Idec-c2b8 (rituximab) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
20 Immunosuppressive treatment (eg, rituximab) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 64 💬
21 Individualized dose of rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 49 💬
22 Intravenous rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 66 💬
23 Mabthera (rituximab) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 4件: 13, 46, 49, 53 💬
24 Mabthera or biosimilar rituximab product Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 13 💬
25 Mabthera® (rituximab) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
26 Originator rituximab - rituxan ® or mabthera ® Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
27 Prednisone, low dose rituximab Prednisone 2件: D00473, D02994 💬 2件: MS4A1, NR3C1 💬 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 1件: 61 💬
28 Rhtpo in combination with rituximab Recombinant Human Thrombopoietin 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 63 💬
29 Rituxan (inn: rituximab), brand name in the united states Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
30 Rituxan (inn: rituximab), brand name in the us Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
31 Rituxan (rituximab) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 49 💬
32 Rituxan® (rituximab) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
33 Rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
34 Rituximab (anti-cd20) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 53 💬
35 Rituximab (arm a) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 2件: 43, 44 💬
36 Rituximab (arm b) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 2件: 43, 44 💬
37 Rituximab (eu) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
38 Rituximab (genetical recombination) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 14 💬
39 Rituximab (mabthera® or rituxan®). Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 2件: 35, 61 💬
40 Rituximab (mabthera®) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 61 💬
41 Rituximab (rituxan) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 11 💬
42 Rituximab (rtx) and azathioprine (aza) Azathioprine 3件: D00238, D02994, D03033 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 65 💬
43 Rituximab (us) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
44 Rituximab - mabthera Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
45 Rituximab 1g iv Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 162 💬
46 Rituximab [mabthera/rituxan] Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 2件: 46, 63 💬
47 Rituximab [mabthera] Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
48 Rituximab and cyclophosphamide iv Cyclophosphamide 3件: D00287, D02994, D07760 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 35 💬
49 Rituximab combined with omalizumab Omalizumab 2件: D02994, D05251 💬 2件: FCER1A, MS4A1 💬 5件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 1件: 162 💬
50 Rituximab infusion Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 2件: 13, 222 💬
51 Rituximab it Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 13 💬
52 Rituximab iv Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 13 💬
53 Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 13 💬
54 Rituximab mabthera Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
55 Rituximab or rituximab hyaluronidase human Hyaluronidase 4件: D02994, D04455, D04456, D06604 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 331 💬
56 Rituximab, mabthera Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 53 💬
57 Rituximab, mtx, folic acid Folic acid 2件: D00070, D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
58 Rituximab, observational study amon patients with active ra Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
59 Rituximab-eu+ rituximab-pfizer x 2 courses Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
60 Rituximab-pfizer Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
61 Rituximab-pfizer (pf-05280586) x 3 courses Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
62 Rituximab-us + rituximab-pfizer x 2 courses Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
63 Rituximab/ mabthera Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 271 💬
64 Sait101 (proposed rituximab biosimilar) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
65 Sait101 (rituximab biosimilar) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
66 Standard dose of rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 49 💬
67 The standard steroid treatment, plasma exchange and rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 85 💬

先頭へ